Immunotherapy Combinations Under Investigation in NSCLC

October 6, 2016
Roy S. Herbst, MD, PhD

Roy S. Herbst, MD, PhD, discusses the immunotherapy combinations under investigation in NSCLC during the IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology.